Bristol-Myers Squibb Co (BMY)
61.88
+0.06 +0.10%
NYSE
Sep 26, 10:26
Delayed 2m
USD
View All Key Stats
BMY Key Stats
| Income Statement | |
| Revenue (TTM) | 21.60B |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | 0.24 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | 376.00M |
| Profitability | |
| Gross Profit Margin (Quarterly) | 71.51% |
| Profit Margin (Quarterly) | 6.54% |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield (TTM) | Upgrade |
| Price and Valuation | |
| Market Cap | 100.98B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio (TTM) | 4.701 |
| PE Ratio (TTM) | 257.83 |
| Price to Book Value | 8.198 |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio (Quarterly) | Upgrade |
| Free Cash Flow (Quarterly) | 859.00M |
| Return on Equity (TTM) | Upgrade |
View All BMY News
BMY News
-
WireHeadlineTime (ET)
-
Yahoo09/26 07:32
-
SA Breaking News09/25 15:51
-
Yahoo09/25 10:10
-
Yahoo09/25 08:29
-
SA Breaking News09/24 16:02
-
Yahoo09/24 10:25
-
Yahoo09/24 10:19
-
SA Breaking News09/24 08:42
-
Yahoo09/21 13:50
-
SA Breaking News09/21 10:07
View All Events
BMY Events
| Date | Type | Description |
|---|---|---|
| 02/05/2019 08:00 EST | Misc | Bristol-Myers Squibb Co Fourth Quarter Earnings Conference Call in 2018 |
| 02/05/2019 | Earnings | Bristol-Myers Squibb Co Fourth Quarter Earnings in 2018 Release |
| 10/25/2018 10:30 EDT | Misc | Bristol-Myers Squibb Co Third Quarter Earnings Conference Call in 2018 |
| 10/25/2018 | Earnings | Bristol-Myers Squibb Co Third Quarter Earnings in 2018 Release |
| 10/04/2018 | Dividends | Amount: 0.40, Declared Date: Sep 12 2018, Pay Date: Nov 01 2018 |
| 07/26/2018 10:30 EDT | Misc | Bristol-Myers Squibb Co Second Quarter Earnings Conference Call in 2018 |
| 07/26/2018 | Earnings | Bristol-Myers Squibb Co Second Quarter Earnings Results in 2018 |
| 07/05/2018 | Dividends | Amount: 0.40, Declared Date: Jun 14 2018, Pay Date: Aug 01 2018 |
| 05/01/2018 | Misc | Bristol-Myers Squibb Co Annual General Meeting in 2017 |
| 04/26/2018 10:30 EDT | Misc | Bristol-Myers Squibb Co First Quarter Earnings Conference Call in 2018 |
BMY Fundamentals
Income Statement View Statement
BMY Ratings
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
Advertisement
BMY One Page Reports
- One Page Report Download
BMY Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Consensus Recommendation | Upgrade |
| Consensus Rating | Upgrade |
| Target Price | |
| Price | 61.88 |
| Price Target | Upgrade |
| Price Target Upside (Daily) | Upgrade |
Edit
Profile
- URL: http://www.bms.com
- Investor Relations URL: N/A
- HQ State/Province: New York
- Sector: Healthcare
- Industry: Drug Manufacturers - Major
- Equity Style: Large Cap/Blend
- Next Earnings Release: Oct. 25, 2018
- Last Earnings Release: Jul. 26, 2018
- Next Ex-Dividend Date: Oct. 04, 2018
- Last Ex-Dividend Date: Jul. 05, 2018
- Description: Bristol-Myers Squibb Co is engaged in discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceuticals products. The company operates in one segment that is Biopharmaceuticals.
BMY Excel Add-In Codes
- Name: =YCI("BMY","name")
- Description: =YCI("BMY","description")
- Sector: =YCI("BMY","sector")
- Industry: =YCI("BMY","industry")
- Est. Current Fiscal Year End: =YCI("BMY","fye")
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.
Other BMY Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- BMY Tweets Stocktwits
Advertisement
